Literature DB >> 1900418

The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

A Leyte1, J Voorberg, H B Van Schijndel, B Duim, H Pannekoek, J A Van Mourik.   

Abstract

We have established that a recombinant von Willebrand Factor (vWF) mutant (vWFdelpro) that lacks the propolypeptide, in contrast with mature wild-type vWF, with which it is identical in terms of primary amino acid sequence, is not able to form a complex with Factor VIII. Wild-type vWF (flvWF) and vWFdelpro were expressed in AtT-20 cells. Under the culture conditions employed, completely processed multimerized flvWF and dimeric vWFdelpro were secreted into the medium. FlvWF and vWFdelpro were compared for their Factor VIII-binding properties in two distinct assay systems. In a direct binding assay, purified human Factor VIII was shown to bind to flvWF that had been immobilized on the surface of microtitre wells by using an anti-vWF monoclonal antibody. In contrast, Factor VIII did not bind to immobilized vWFdelpro. In a competition assay, fluid-phase flvWF appeared to inhibit efficiently the binding of Factor VIII to immobilized vWF isolated from plasma, whereas vWFdelpro did not influence Factor VIII binding. From these observations, it is argued that the pro-polypeptide serves an essential role in the post-translational processes that lead to the expression of a functional Factor VIII-binding site on the mature vWF subunit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900418      PMCID: PMC1149946          DOI: 10.1042/bj2740257

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

Authors:  L O Andersson; N Forsman; K Huang; K Larsen; A Lundin; B Pavlu; H Sandberg; K Sewerin; J Smart
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

Authors:  D Eaton; H Rodriguez; G A Vehar
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

3.  The size of human factor VIII heterodimers and the effects produced by thrombin.

Authors:  P J Fay; M T Anderson; S I Chavin; V J Marder
Journal:  Biochim Biophys Acta       Date:  1986-06-23

4.  Cloning and characterization of two cDNAs coding for human von Willebrand factor.

Authors:  J E Sadler; B B Shelton-Inloes; J M Sorace; J M Harlan; K Titani; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers.

Authors:  R J Wise; D D Pittman; R I Handin; R J Kaufman; S H Orkin
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor.

Authors:  P A Foster; C A Fulcher; T Marti; K Titani; T S Zimmerman
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

7.  Association of the factor VIII light chain with von Willebrand factor.

Authors:  P Lollar; D C Hill-Eubanks; C G Parker
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

8.  Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.

Authors:  K M Brinkhous; H Sandberg; J B Garris; C Mattsson; M Palm; T Griggs; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.

Authors:  C L Verweij; P J Diergaarde; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

10.  Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation.

Authors:  C L Verweij; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more
  6 in total

1.  Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.

Authors:  A Preininger; U Schlokat; G Mohr; M Himmelspach; V Stichler; A Kyd-Rebenburg; B Plaimauer; P L Turecek; H P Schwarz; W Wernhart; B E Fischer; F Dorner
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

2.  Distinct roles of Ser-764 and Lys-773 at the N terminus of von Willebrand factor in complex assembly with coagulation factor VIII.

Authors:  Lydia Castro-Núñez; Esther Bloem; Mariëtte G Boon-Spijker; Carmen van der Zwaan; Maartje van den Biggelaar; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2012-11-20       Impact factor: 5.157

3.  Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.

Authors:  T N Mayadas; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.

Authors:  M J Donath; R T de Laaf; P T Biessels; P J Lenting; J W van de Loo; J A van Mourik; J Voorberg; K Mertens
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

5.  Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.

Authors:  Lisbeth Dagil; Kathrin S Troelsen; Gert Bolt; Lars Thim; Bo Wu; Xin Zhao; Edward G D Tuddenham; Thomas E Nielsen; David A Tanner; Johan H Faber; Jens Breinholt; Jakob E Rasmussen; D Flemming Hansen
Journal:  Biophys J       Date:  2019-07-11       Impact factor: 4.033

6.  Protein residue network analysis reveals fundamental properties of the human coagulation factor VIII.

Authors:  Tiago J S Lopes; Ricardo Rios; Tatiane Nogueira; Rodrigo F Mello
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.